Urgent.News

600+ sources. One page. See who else covered it.

Editions

Health & Medicine

PDUFA VIII commitments: 'America First' provisions, faster reviews and more

The FDA's next five-year reauthorization of the prescription drug user fee program will feature new incentives for domestic pharma companies, newly sped up reviews for some applications and improved ways for industry to communicate with ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Thursday 13 August →